TIDMGWP

RNS Number : 8355P

GW Pharmaceuticals PLC

22 November 2016

GW Pharmaceuticals to Present at the 28(th) Annual Piper Jaffray Healthcare Conference on 29 November

London, UK, 22 November 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW's Chief Executive Officer, will present at the 28(th) Annual Piper Jaffray Healthcare Conference on Tuesday, 29 November 2016, at 10:30 a.m. ET at the Lotte New York Palace, New York City.

A live audio webcast of the presentation will be available through GW's corporate website in the investor relations section from the investor's calendar of events page at www.gwpharm.com. A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex(R) (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, Tuberous Sclerosis Complex and Infantile Spasms. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 30 countries outside the United States. The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, schizophrenia and epilepsy. For further information, please visit www.gwpharm.com.

Enquiries:

 
 GW Pharmaceuticals plc 
 Stephen Schultz, VP Investor    917 280 2424 / 401 500 
  Relations (U.S.)                6570 
 
 Peel Hunt LLP (UK NOMAD) 
 James Steel                     +44 20 7418 8900

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCKMMZMMZZGVZM

(END) Dow Jones Newswires

November 22, 2016 08:00 ET (13:00 GMT)

Gw Pharmaceuticals (LSE:GWP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Gw Pharmaceuticals.
Gw Pharmaceuticals (LSE:GWP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Gw Pharmaceuticals.